Goodwin Advises Incyte in Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Incyte's Hematology Portfolio into Bleeding Disorders
June 12, 2026
June 12, 2026
BOSTON, Massachusetts, June 12 [Category: BizLaw/Legal] -- Goodwin, a law firm, posted the following news release:
* * *
Goodwin Advises Incyte in Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Incyte's Hematology Portfolio into Bleeding Disorders
*
The Life Sciences team advised Incyte (Nasdaq: INCY) in its definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of St . . .
* * *
Goodwin Advises Incyte in Acquisition of Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding Incyte's Hematology Portfolio into Bleeding Disorders
*
The Life Sciences team advised Incyte (Nasdaq: INCY) in its definitive agreement to acquire Vega Therapeutics, Inc., a wholly owned subsidiary of St . . .